Cleocin Phosphate (clindamycin) Injection and (clindamycin injection in 5% dextrose) Solution in Galaxy Plastic Containers
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
ADVERSE REACTIONS
An unpleasant or metallic taste has been reported after intravenous administration of the higher doses...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Clindamycin | Drugs & Pharmacology